Projects funded by the NCN
The development of the new safe and controlled anticoagulant therapy with the use of cationically-modified polymers in the models of experimentally induced arterial and venous thrombosis.
2011/03/B/NZ7/00755
Keywords:
heparin coagulation thrombosis anticoagulants
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 11
Call: OPUS 2 - announced on 2011-09-15
Amount awarded: 588 010 PLN
Project start date (Y-m-d): 2012-08-22
Project end date (Y-m-d): 2015-08-21
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled